Physician profile
Susan E Kohl
NPI 1528098811
$3,333.62
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $396 · 2021: $626 · 2022: $588 · 2023: $68.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $513.81 | 2019-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $384.81 | 2019-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $326.71 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $307.98 | 2019-2022 | |
| Astellas Pharma US INC | $286.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.99 | 2019-2022 | |
| Vifor Pharma, INC. | $207.19 | 2019 | |
| Pfizer INC. | $201.02 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $169.24 | 2019-2020 | |
| Csl Behring | $164.08 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $149.58 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $51.84 | 2019-2020 | |
| Shionogi INC | $50.57 | 2022 | |
| Gilead Sciences, INC. | $47.11 | 2021 | |
| Alexion Pharmaceuticals, INC. | $43.74 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $32.71 | 2021 | |
| Mylan Specialty L.P. | $29.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.05 | 2019 | |
| Novo Nordisk INC | $22.47 | 2019 | |
| Eusa Pharma (US) LLC | $19.17 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $19.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Kohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.